These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8152306)

  • 41. Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens.
    Noguchi Y; Tateno M; Kondo N; Yoshiki T; Shida H; Nakayama E; Shiku H
    J Immunol; 1989 Dec; 143(11):3737-42. PubMed ID: 2479689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Expression of the gene for the gp46 surface glycoprotein from the human T-cell leukemia virus type I (HTLV-I) in bacteria].
    Sankov MN; Bobkov AF; Garaev MM
    Mol Gen Mikrobiol Virusol; 1994; (3):23-5. PubMed ID: 8065380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different HTLV-I neutralization patterns among sera of patients infected with cosmopolitan HTLV-I.
    Blanchard S; Astier-Gin T; Moynet D; Edouard E; Guillemain B
    Virology; 1998 May; 245(1):90-8. PubMed ID: 9614870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SIV envelope glycoprotein epitopes recognized by antibodies from infected or vaccinated rhesus macaques.
    Torres JV; Anderson DE; Malley A; Banapour B; Axthelm MK; Benjamini E; Gardner MB
    J Med Primatol; 1993; 22(2-3):129-37. PubMed ID: 7692056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural and immunogenicity analysis of chimeric B-cell epitope constructs derived from the gp46 and gp21 subunits of the envelope glycoproteins of HTLV-1.
    Sundaram R; Beebe M; Kaumaya PT
    J Pept Res; 2004 Feb; 63(2):132-40. PubMed ID: 15009534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Probing the conformation of the human T-lymphotropic virus I envelope protein complex with monoclonal antibodies.
    Carrington CV; Paul N; Cordell J; Schulz TF
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2025-9. PubMed ID: 8810999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HTLV-II-specific antisera raised in rabbits immunized with a synthetic peptide of HTLV-II envelope protein.
    Hayashi K; Ohara N; Fujiwara K; Jeon HJ; Koirala TR; Takahashi K; Akagi T; Tomita N; Miyamoto K
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 63(1):37-41. PubMed ID: 1362020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.
    Viscidi RP; Hill PM; Li SJ; Cerny EH; Vlahov D; Farzadegan H; Halsey N; Kelen GD; Quinn TC
    J Acquir Immune Defic Syndr (1988); 1991; 4(12):1190-8. PubMed ID: 1941526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and CD studies of an 88-residue peptide containing the main receptor binding site of HTLV-I SU-glycoprotein.
    Goetz M; Geoffre S; Busetta B; Manigand C; Nespoulous C; Londos-Gagliardi D; Guillemain B; Hospital M
    J Pept Sci; 1997; 3(5):347-53. PubMed ID: 9391909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia.
    Loughran TP; Hadlock KG; Perzova R; Gentile TC; Yang Q; Foung SK; Poiesz BJ
    Br J Haematol; 1998 May; 101(2):318-24. PubMed ID: 9609528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.
    Lycke J; Andersen O; Svennerholm B; Ben-Menachem E; Horal P; Vahlne A
    Acta Neurol Scand; 1992 Jan; 85(1):44-54. PubMed ID: 1546533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.
    Kuroda N; Washitani Y; Shiraki H; Kiyokawa H; Ohno M; Sato H; Maeda Y
    Int J Cancer; 1990 May; 45(5):865-8. PubMed ID: 2185995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HTLV-I in Burundi (east Africa): lack of reactivity to the HTLV-I immunodominant envelope epitope.
    Bonis J; Preux PM; Nzisabira L; Letenneur L; Muhirwa G; Buzingo T; Kamuragiye A; Preux C; Ngoga E; Dumas M
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1099-100. PubMed ID: 8083828
    [No Abstract]   [Full Text] [Related]  

  • 54. A wide spectrum of collagen vascular and autoimmune diseases in transgenic rats carrying the env-pX gene of human T lymphocyte virus type I.
    Yamazaki H; Ikeda H; Ishizu A; Nakamaru Y; Sugaya T; Kikuchi K; Yamada S; Wakisaka A; Kasai N; Koike T; Hatanaka M; Yoshiki T
    Int Immunol; 1997 Feb; 9(2):339-46. PubMed ID: 9040015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies.
    Blanchard S; Astier-Gin T; Tallet B; Moynet D; Londos-Gagliardi D; Guillemain B
    J Virol; 1999 Nov; 73(11):9369-76. PubMed ID: 10516045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recognition by human sera of a variable region of the surface glycoprotein of HTLV-I.
    Edouard E; Londos-Gagliardi D; Busetta B; Geoffre S; Dalbon P; Moreau JP; Guillemain B
    Leukemia; 1994 Apr; 8 Suppl 1():S65-7. PubMed ID: 8152306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of monoclonal antibodies directed against the gp46 of human T-cell leukemia virus type I.
    Edouard E; Legrand E; Astier-Gin T; Dalibart R; Geoffre S; Dalbon P; Guillemain B; Londos-Gagliardi D
    Leukemia; 1994 Apr; 8 Suppl 1():S60-4. PubMed ID: 7512182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.
    Londos-Gagliardi D; Dalibart R; Geoffre S; Dalbon P; Pouliquen JF; Georges-Courbot MC; Sainte-Foie S; Hajjar C; Georges AJ; Moreau JP; Guillemain B
    AIDS Res Hum Retroviruses; 1996 Jul; 12(10):941-50. PubMed ID: 8798979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
    Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
    Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies.
    Tallet B; Astier-Gin T; Moynet D; Londos-Gagliardi D; Guillemain B
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):337-48. PubMed ID: 11242520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.